Investors are starting to brace for the Fed's policy decision after its meeting, which begins today.
Actualités
Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.
Investors are starting to brace for the Fed's policy decision after its meeting, which begins today.
US stock futures wavered as investors shifted their focus from the US-Iran deal announcement to the Federal Reserve's policy meeting.
All eyes will be on new Fed chair Kevin Warsh.
In the latest trading session, Rithm (RITM) closed at $9.19, marking a -1.29% move from the previous day.
Annaly Capital Management (NLY) closed at $22.24 in the latest trading session, marking a +1.09% move from the prior day.
Diamondback Energy (FANG) reached $189.96 at the closing of the latest trading day, reflecting a -1.13% change compared to its last close.
The latest trading day saw Main Street Capital (MAIN) settling at $51.29, representing a -1.4% change from its previous close.
Today, June 15, 2026, investors analyze a $2.75 billion cash buyout for Payoneer from Nuvei.
Since December 2025, SouthState has been in a holding pattern, posting a small return of 1.9% while floating around $98.95. The stock also fell short of the S&P 500’s 8.4% gain during that period.
President Donald Trump and Vice President JD Vance signed an electronic copy of a memorandum of understanding with Iran, a senior US official said in a call with reporters.
Blue Bird (BLBD) closed at $72.86 in the latest trading session, marking a +1.85% move from the prior day.
Jazz Pharmaceuticals has had an impressive run over the past six months as its shares have beaten the S&P 500 by 28.7%. The stock now trades at $232.44, marking a 37.1% gain. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.
Over the past six months, First Bancorp has been a great trade, beating the S&P 500 by 7.2%. Its stock price has climbed to $61.79, representing a healthy 15.6% increase. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
Investors weigh fresh details from a Jefferies consumer survey on eVOTLs today, June 15, 2026.
(Oil & Gas 360) – The Fracking Revolution Working Here & Freedom Growing Over There Have UP The Direction We Head With […]
Over the past six months, Meta’s stock price fell to $569.25. Shareholders have lost 12.1% of their capital, which is disappointing considering the S&P 500 has climbed by 8.4%. This might have investors contemplating their next move.
Luxfer has had an impressive run over the past six months as its shares have beaten the S&P 500 by 23.2%. The stock now trades at $18.07, marking a 31.6% gain. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.
(Updates with index/price moves, macroeconomic data, and political/company news from the first parag
Over the past six months, Prudential’s shares (currently trading at $108.28) have posted a disappointing 7.9% loss, well below the S&P 500’s 8.4% gain. This might have investors contemplating their next move.
Over the past six months, RLI’s stock price fell to $54.37. Shareholders have lost 16.4% of their capital, which is disappointing considering the S&P 500 has climbed by 8.4%. This may have investors wondering how to approach the situation.
Major digital assets rose Monday, with Bitcoin (BTC-USD) topping $66,000. The CoinDesk Market Ind
SpaceX Rockets Past Palantir in Stunning Post-IPO Valuation Race
The Nasdaq had its best day since March after Wall Street used the U.S.-Iran peace deal as just another excuse to pile into technology stocks. The Dow rose 469 points, or 0.9%. Market breadth was actually mediocre, but everything from Big Tech to software and chips were on the rise, along with other risk assets like crypto firms.
Warby Parker has been treading water for the past six months, recording a small loss of 1.5% while holding steady at $26.43. The stock also fell short of the S&P 500’s 8.4% gain during that period.
Cigna trades at $298.08 and has moved in lockstep with the market. Its shares have returned 7.6% over the last six months while the S&P 500 has gained 8.4%.
(Updates with index/price moves and political news from the first paragraph.) US equity indexes s